Amyloid Plaques - Hall mark of Alzheimer's Disease
Doctor Brian Bacskai discusses how Amyloid plaques lead to a definitive diagnosis of alzheimer's disease.
Amyloid plaques are a histopathological hallmark of Alzheimerâ€™s disease, They lead to the definitive diagnosis of Alzheimerâ€™s disease in patients at post mortem autopsy. They are comprised primarily of the Abeta (amyloid beta) peptide, which accumulates over time and deposits as these sort of roughly spherical conglomerates of Abeta peptide and a variety of other peptides and cellular debris.
amyloid plaques, cellular debris, definitive diagnosis, conglomerates, post mortem, peptide, autopsy, Brian, Bacskai
Professor Donna Wilcock describes amyloid plaques as clumps of protein in the brain that are one of the three hallmarks of Alzheimer's disease.
Professor Donna Wilcock discusses a new biological technique for diagnosing Alzheimer's disease using PET neuroimaging.
Doctor Brian Bacskai explaine that senile plaques lead to an increase in resting calcium in astrocytes in the entire brain.
Doctor Brian Bacskai discusses the potential of manipulating calcium levels in the brain as a potential therapy for ALzheimer's disease.
Neuroimaging techniques help scientists visualize Alzheimer's disease before the disease becomes debilitating.
Doctor Brian Bacskai discusses how his group uses optical image to record plaque formation in Alzheimer's-type mice.
Bio-barcode amplification (BCA) is a new technique that can search for biological markers of Alzheimer's disease, which may lead to earlier diagnosis.
Alzheimer's disease is characterized by abnormal plaques and tangles in the brains of patients.
Doctor Brian Bacskai define astrocytes, or astroglia as brain cells that have an active structural role in keeping the brain together.
Alzheimer’s disease is a progressive brain disorder that causes a gradual and irreversible loss of higher brain functions, including memory, language skills, and perception of time and space,